| Title： | Chinese consensus statement: diagnosis and treatment of cystic fibrosis (2022) |
| Edition： | Original |
| Classification： | Experts consensus |
| Field： | Diagnosis and Treatment |
| Countries and regions： | China |
| Guidelines users： | |
| Evidence classification method： | A(Good), B(Fair), C(Low), D(Expert Opinion) |
| Development unit： | Expert Consensus Group of Chinese Cystic Fibrosis, The Rare Lung Disease Alliance, China Alliance of Rare Diseases, China Bronchiectasis Alliance |
| Registration time: | 2022-03-23 |
| Registration number： | IPGRP-2022CN167 |
| Purpose of the guideline: |
Latest registration
